Company Filing History:
Years Active: 2015-2016
Title: Alan Main: Innovator in Pharmaceutical Compounds
Introduction
Alan Main is a notable inventor based in Far Hills, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds aimed at treating various diseases.
Latest Patents
Alan Main holds 3 patents that showcase his expertise in creating novel compounds. His latest patents include Pyrazolo[1,5-a]pyrimidine-based compounds, which are designed to treat, manage, and prevent diseases mediated by adaptor associated kinase 1 activity. These compounds are characterized by specific formulas where R, R, and R are defined in the patent documentation. Additionally, he has developed Imidazo[1,2-b]pyridazine-based compounds, which also target diseases associated with adaptor associated kinase 1 activity, providing further options for therapeutic interventions.
Career Highlights
Alan Main is currently associated with Lexicon Pharmaceuticals, Inc., where he continues to innovate and contribute to the pharmaceutical industry. His work focuses on the development of compounds that have the potential to address significant health challenges.
Collaborations
Some of his notable coworkers include Yingzhi Bi and Kenneth Gordon Carson, who collaborate with him in advancing research and development in their field.
Conclusion
Alan Main's contributions to pharmaceutical innovations through his patents and work at Lexicon Pharmaceuticals, Inc. highlight his role as a key inventor in the industry. His ongoing research promises to lead to advancements in treatments for various diseases.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.